Compounded "semaglutide" is not FDA approved semaglutide.com The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA moves toward easing restrictions on certain peptides BioPharma Dive The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps BPC 157 for athletes and injury treatment: Science, safety, and legal concerns